Physician

Nathan Christopher Steinle, M.D.

According to 2025 Medicare claims, Nathan Steinle, M.D. (NPI: 1942455423) practices ophthalmology in the San Luis Obispo-Paso Robles, CA market, with the plurality of this provider's patient population coming from San Luis Obispo, CA. This provider's primary affiliated billing organization is CALIFORNIA RETINA CONSULTANTS (NPI: 1386737617; TIN: 223697030) and primary practice location at 93401-8741.

Steinle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,051 traditional Medicare patients, billed 220,352 HCPCS/CPT codes, and received $9,812,656 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 2,210 prescription claims across 561 beneficiaries totaling $108,175 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 109 records totaling $189,107. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,133,288 to $9,812,656. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,910	34,171	$5,133,288
2016	1,926	35,663	$4,882,773
2017	2,023	36,718	$5,209,777
2018	2,091	40,937	$5,958,333
2019	2,203	45,352	$6,721,662
2020	2,603	40,386	$7,042,021
2021	2,601	41,661	$7,177,626
2022	2,812	50,571	$7,853,158
2023	3,065	85,113	$9,520,341
2024	3,051	220,352	$9,812,656

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	226	750	$61,412
2016	256	948	$78,278
2017	328	1,210	$115,416
2018	386	1,496	$112,633
2019	399	1,552	$136,639
2020	453	1,959	$156,582
2021	447	1,945	$161,988
2022	473	1,892	$136,436
2023	557	2,136	$134,020
2024	561	2,210	$108,175

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	1,082	4,679	$114
92014	Established patient complete exam of visual system	2,157	4,004	$96
92012	Established patient problem focused exam of visual system	1,439	2,705	$79
92134	Imaging of retina	2,856	8,522	$34
92202	Extended exam of the back part of the eye with optic nerve drawing	1,186	1,769	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	695	27,239	$22,414
Lumigan	Bimatoprost	37	2,058	$21,426
Brimonidine Tartrate	Brimonidine Tartrate	126	6,087	$5,186
Cyclosporine	Cyclosporine	16	720	$3,677
Alphagan P	Brimonidine Tartrate	11	330	$3,633

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	98	$137,030	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$52,077	Apellis Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nathan Christopher Steinle, M.D.?

Tedicare shows public-source Medicare data for Nathan Christopher Steinle, M.D. (NPI 1942455423), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathan Christopher Steinle, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nathan Christopher Steinle, M.D.?

Nathan Christopher Steinle, M.D. is linked to CALIFORNIA RETINA CONSULTANTS (billing NPI 1386737617) in the available physician profile data.

Does Nathan Christopher Steinle, M.D. have Open Payments data?

Nathan Christopher Steinle, M.D. has 109 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.